Pharmacology Watch – November 1, 2016
November 1, 2016
View Issues
-
New Study Compares Leading Atrial Fibrillation Treatments
The authors concluded that rivaroxaban use for atrial fibrillation was associated with significantly higher rates of intracranial hemorrhage and major extracranial bleeding.
-
New Erectile Dysfunction Data Counter Previous Studies
This study will be a relief for men who take 5-alpha reductase inhibitors, since previous studies suggested erectile dysfunction may be a significant problem with these drugs.
-
Experts Withdraw Support for Codeine in Children
After years of debate, the American Academy of Pediatrics has issued a Clinical Report recommending against the use of codeine for cough or pain in children, regardless of age.
-
FDA Actions
In this section: FDA removes black box warning from Chantix; approves first biosimilar to Humira; issues warning about hepatitis C drug; and green lights first drug to treat common childhood form of muscular dystrophy.